CERT Certara
- 17.600
- -0.010-0.06%
- 17.600
- 0.0000.00%
Certara News
Top Ideas in Vertical Software With Valuations Over or Below 50th Percentile - Baird
Certara Launches Cloud Platform to Unify Scientific Software Solutions
Certara (CERT) said Tuesday it has launched Certara Cloud to integrate its many scientific software solutions. Customers log into Certara Cloud using a single ID to access and manage their software, l
Certara Launches Cloud Platform to Further Unify Its End-to-End Scientific Software Platform
Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of Certara Cloud, the unifying platform that integrates its many scientific software solutions.
Should You Investigate Certara, Inc. (NASDAQ:CERT) At US$18.46?
While Certara, Inc. (NASDAQ:CERT) might not have the largest market cap around , it saw a decent share price growth of 18% on the NASDAQGS over the last few months. The recent rally in share pri
Sector Update: Health Care Stocks Slipping Late Afternoon
Health care stocks declined late Wednesday afternoon, with the NYSE Health Care Index shedding 0.9% and the Health Care Select Sector SPDR Fund (XLV) falling 1.1%. The iShares Biotechnology ETF (IBB)
R1 RCM, Health Catalyst Downgraded as KeyBanc Reviews Health-tech Space
Certara Poised to Benefit From Improving End Markets, KeyBanc Says
Certara (CERT) is poised to benefit from improving end markets, KeyBanc Capital Markets said in a note Tuesday. KeyBanc said it increased its estimates for Certara along with its "higher conviction of
Express News | Certara Shares Are Trading Higher After KeyBanc Upgraded the Stock From Sector Weight to Overweight
Certara Price Target Announced at $23.00/Share by Keybanc
Certara Price Target Announced at $23.00/Share by Keybanc
Certara Raised to Overweight From Sector Weight by Keybanc
Certara Raised to Overweight From Sector Weight by Keybanc
Express News | Keybanc Upgrades Certara to Overweight, Announces $23 Price Target
Barclays Remains a Hold on Certara (CERT)
Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference
PRINCETON, N.J., April 09, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in biosimulation, today announced that it will release financial results for the first quarter of 2024 after the market
Insider Sell: President of Drug Dev Solutions at Certara Inc (CERT) Sells Shares
Certara(CERT.US) Officer Sells US$243.16K in Common Stock
$Certara(CERT.US)$ Officer SMITH PATRICK F sold 14,427 shares of Common Stock on Apr 2, 2024 at an average price of $16.85 for a total value of $243.16K.Source: Announcement What is statement of chang
Certara Shares Rise After JMP Securities Starts Coverage at Market Perform
Certara (CERT) shares rose more than 6% in recent Thursday trading after JMP Securities initiated coverage on the company with a market perform rating. Intraday volume stood at more than 391,000 share
Decoding 4 Analyst Evaluations For Certara
During the last three months, 4 analysts shared their evaluations of Certara (NASDAQ:CERT), revealing diverse outlooks from bullish to bearish.The table below offers a condensed view of their recent r
Certara Initiated at Market Perform by JMP Securities
Certara Initiated at Market Perform by JMP Securities
Express News | JMP Securities Initiates Coverage On Certara With Market Perform Rating
Maintaining Hold Rating for Certara Amid Balanced Financials and Industry Headwinds
Analysis
Price Target
No Data
